The effects of conjugated linoleic acid (cla) supplementation on metabolic syndrome factors: a systematic review and meta-analysis of randomized clinical trials

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: KIM, Boyeon (SO&COMPANY, Account Division, Korea, Republic Of)
  • Co-author(s): Boyeon Kim: Account Division, SO&COMPANY, Seoul, Korea, Republic Of;Pharmacy, Chung-Ang University, Seoul, Korea, Republic Of
    Harae Lim: The Graduate School of Food and Drug Administration, Chung-Ang University, Seoul, Korea, Republic Of
    Eunyoung Kim: Pharmacy, Chung-Ang University, Seoul, Korea, Republic Of
  • Abstract:

    Background

    Metabolic syndrome (MS) is a cluster of risk factors that includes hypertension, diabetes, abdominal obesity, and dyslipidemia. In general, obesity is considered the major component of the syndrome. Presently, conjugated linoleic acid (CLA) has received significant attention because recent data have shown its anti-obesity effects in..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login